These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18094002)

  • 1. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1).
    Sugiyama N; Nakashima H; Yoshimura T; Sadanaga A; Shimizu S; Masutani K; Igawa T; Akahoshi M; Miyake K; Takeda A; Yoshimura A; Hamano S; Yoshida H
    Ann Rheum Dis; 2008 Oct; 67(10):1461-7. PubMed ID: 18094002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Epstein-Barr virus-induced gene 3 protein (EBI3) in MRL/lpr mice suppresses their lupus nephritis by activating regulatory T cells.
    Shinsuke N; Hiroshi I
    Autoimmunity; 2013 Nov; 46(7):446-54. PubMed ID: 23845089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J; Li Q; Yang X; Li M
    Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-specific overexpression of interleukin-27 receptor α subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice.
    Kido M; Takeuchi S; Sugiyama N; Esaki H; Nakashima H; Yoshida H; Furue M
    Br J Dermatol; 2011 Jun; 164(6):1214-20. PubMed ID: 21332454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1).
    Shimizu S; Sugiyama N; Masutani K; Sadanaga A; Miyazaki Y; Inoue Y; Akahoshi M; Katafuchi R; Hirakata H; Harada M; Hamano S; Nakashima H; Yoshida H
    J Immunol; 2005 Dec; 175(11):7185-92. PubMed ID: 16301622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain.
    Neumann D; Del Giudice E; Ciaramella A; Boraschi D; Bossù P
    J Immunol; 2001 Mar; 166(6):3757-62. PubMed ID: 11238617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
    Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
    J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 regulates murine lupus.
    Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
    J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calorie restriction modulates lymphocyte subset phenotype and increases apoptosis in MRL/lpr mice.
    Luan X; Zhao W; Chandrasekar B; Fernandes G
    Immunol Lett; 1995 Sep; 47(3):181-6. PubMed ID: 8747716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L; Takeda K; Akkoyunlu M
    Front Immunol; 2020; 11():1569. PubMed ID: 32849532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.